Filing Details

Accession Number:
0001209191-15-025036
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-11 12:57:56
Reporting Period:
2015-03-09
Filing Date:
2015-03-11
Accepted Time:
2015-03-11 12:57:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1276591 Hansen Medical Inc HNSN Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1512977 Foundation Family Schuler 28161 N. Keith Drive
Lake Forest IL 60045
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Series A Convertible Participating Preferred Stock Acquisiton 2015-03-09 23,077 $650.00 23,077 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant (Right to Buy Common Stock) Acquisiton 2015-03-09 23,077,000 $0.00 23,077,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
23,077,000 No 4 A Direct
Footnotes
  1. Par value $0.0001 per share.
  2. The exercise price for the warrants will be the lesser of $0.975 per share or a 50% premium on the per share trailing weighted average share price of the Common Stock on NASDAQ for the ten trading days ending on dates specified in the form of warrants filed with the SEC.
  3. The warrant shall be exercisable at any time after the date of issuance of the warrant, which shall be the closing date (the "Issuance Date") under the Securities Purchase Agreement, dated March 9, 2015 (the "Purchase Agreement"), to which the reporting person and the issuer are parties.
  4. The expiration date of the warrants will be the date that is two years following the Issuance Date.
  5. Pursuant to the Purchase Agreement, the reporting person agreed to purchase from the issuer shares of Preferred Stock at a price of $650.00 per share and the issuer agreed to issue warrants to the reporting person.